Frontlight ResearchEarly access
Triple-negative breast cancer trials in Slovenia
1 trial · From EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in SloveniaCELL-BASED IMMUNOTHERAPY FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER STAGES II AND III
- Where
- Ljubljana
- Age
- 18 years and over
- People
- 82
- Run by
- Celica d.o.o.
See details and how to join2023-506019-16-03